What Makes CenterPoint (CNP) a New Buy Stock
CenterPoint (CNP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CNP - CenterPoint Energy, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$45.78
DETAILS
HIGH:
$50.00
LOW:
$40.00
MEDIAN:
$46.00
CONSENSUS:
$45.78
UPSIDE:
2.74%
Stock News
CenterPoint Energy (CNP) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CenterPoint (CNP) have what it takes?
Is CenterPoint Energy (CNP) Stock Outpacing Its Utilities Peers This Year?
Here is how CenterPoint Energy (CNP) and Evergy Inc (EVRG) have performed compared to their sector so far this year.
Bessemer Group Inc. Has $2.29 Million Position in CenterPoint Energy, Inc. $CNP
Bessemer Group Inc. lifted its holdings in shares of CenterPoint Energy, Inc. (NYSE: CNP) by 38.5% during the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 53,141 shares of the utilities provider's stock after purchasing an additional 14,762 shares during the period. Bessemer Group Inc.'s holdings in
Andra AP fonden Purchases Shares of 103,900 CenterPoint Energy, Inc. $CNP
Andra AP fonden purchased a new position in shares of CenterPoint Energy, Inc. (NYSE: CNP) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 103,900 shares of the utilities provider's stock, valued at approximately $4,484,000. Other institutional investors have also modified their holdings
CenterPoint Energy (CNP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CenterPoint (CNP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks That Recently Hiked Dividends Amid Geopolitical Tensions
SJM, PPG, SPFI and CNP recently raised dividends, offering income potential as geopolitical tensions fuel market volatility.
California Public Employees Retirement System Sells 453,643 Shares of CenterPoint Energy, Inc. $CNP
California Public Employees Retirement System lowered its stake in shares of CenterPoint Energy, Inc. (NYSE: CNP) by 27.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,194,133 shares of the utilities provider's stock after selling 453,643 shares during the period.
Dividend Champion, Contender, And Challenger Highlights: Week Of July 19
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
CenterPoint Energy Declares Regular Common Stock Dividend of $0.2400
HOUSTON, July 16, 2026 /PRNewswire/ -- CenterPoint Energy, Inc.'s (NYSE: CNP) Board of Directors yesterday declared a regular quarterly cash dividend of $0.2400 per share on the issued and outstanding shares of Common Stock payable on September 10, 2026, to shareholders of record at the close of business on August 20, 2026. This represents a $0.0100 increase over the April 2026 declared dividend per share and in line with CenterPoint's targeted annual dividend per share growth rate of 6%.
2 Retirement Income Powerhouses For Inflationary Times
Persistent, structurally elevated inflation necessitates repositioning portfolios toward higher-yielding, inflation-resilient income products. The risk is that on a real portfolio income growth basis, the necessary wealth accumulation (or preservation) won't simply be there. Yet we have to be cognizant of not falling into the other extreme of elevated NAV destruction or dividend cut risks.
US power companies scramble to secure equipment as surging data center demand strains supplies
Skyrocketing demand from artificial intelligence data centers is exacerbating shortages of critical grid equipment like transformers across the U.S., driving up costs, stretching out wait times and spurring utilities and developers to lock in orders far in advance.
CenterPoint Energy, Inc. to Host Webcast of Second Quarter 2026 Earnings Conference Call on July 28, 2026
Houston, TX, July 07, 2026 (GLOBE NEWSWIRE) -- CenterPoint Energy, Inc. (NYSE: CNP) announces the following webcast - - Date: July 7, 2026 Time: 5:00 PM ET Listen via Internet: http://investors. centerpointenergy. com/ Click the link "CenterPoint Energy, Inc. Second Quarter 2026 Earnings Conference Call Webcast" Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.
CenterPoint Energy, Inc. to Host Webcast of Second Quarter 2026 Earnings Conference Call on July 28, 2026
Houston, TX, July 07, 2026 (GLOBE NEWSWIRE) -- CenterPoint Energy, Inc. (NYSE:CNP) announces the following webcast - - Date: July 7, 2026 Time: 5:00 PM ET Listen via Internet: http://investors.centerpointenergy.com/ Click the link "CenterPoint Energy, Inc. Second Quarter 2026 Earnings Conference Call Webcast" Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=71418&k=8861E677
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
COPENHAGEN, Denmark, June 30, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new radiographic data from Week 104 from the completed pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) in children with achondroplasia. In the trial, TransCon CNP-treated children demonstrated continued improvements in lower extremity alignment through up to two years of treatment, including improvements in tibial-femoral angle (TFA). As previously reported, improvements in annualized growth velocity were maintained and ACH-specific height Z-score increased with TransCon CNP treatment through Week 104. The data were presented by Leanne M. Ward, M.D., FRCPC, Professor of Pediatrics at the University of Ottawa and Children's Hospital of Eastern Ontario, during the 12th International Conference on Children's Bone Health (ICCBH 2026) held in Montreal, Canada.
CNP vs. ES: Which Utility Stock Offers Better Return Potential?
CenterPoint Energy and Eversource Energy both benefit from rising power demand and grid investments, but debt, ROE, dividends and price gains set up a sharper utility stock comparison.
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CenterPoint (CNP) have what it takes?
Algonquin Power & Utilities vs. CenterPoint Energy: Which Utilities Stock Is a Better Buy in 2026?
Revenue growth, profit margins, and risk profiles set these two utility giants apart, here's how their financials and valuations stack up for 2026 portfolios.
Now Is a Good Time to Buy Into America's Mega Utility Merger
The largest U.S. utility is about to buy Dominion Energy, a big peer with data-center exposure. What's not to like?
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Price Targets
CenterPoint Energy price target lowered to $46 from $47 at KeyBanc
$46.00
(was $43.68)
Sophie Karp
·
KeyBanc
CenterPoint Energy price target raised to $40 from $39 at Morgan Stanley
$40.00
(was $43.43)
David Arcaro
·
Morgan Stanley
CenterPoint Energy price target raised to $48 from $47 at BMO Capital
$48.00
(was $43.12)
BMO Capital
CenterPoint Energy (CNP) PT Raised to $50 at JefferiesMember Login
$50.00
(was $42.82)
Jefferies
CenterPoint Energy price target lowered to $47 from $48 at Truist
$47.00
(was $41.53)
Richard Sunderland
·
Truist Financial
CenterPoint Energy price target raised to $45 from $44 at Evercore ISI
$45.00
(was $43.52)
Evercore ISI
CenterPoint Energy price target raised to $48 from $47 at Wells Fargo
$48.00
(was $42.70)
Wells Fargo
CenterPoint Energy price target raised to $49 from $44 at Jefferies
$49.00
(was $42.83)
Julien Dumoulin-Smith
·
Jefferies
CenterPoint Energy price target raised to $44 from $38 at Barclays
$44.00
(was $42.90)
Barclays
CenterPoint Energy price target raised to $44 from $42 at Mizuho
$44.00
(was $43.00)
Mizuho Securities
CenterPoint Energy price target raised to $37 from $36 at Morgan Stanley
$37.00
(was $39.59)
Morgan Stanley
CenterPoint Energy price target raised to $47 from $44 at Wells Fargo
$47.00
(was $39.71)
Shahriar Pourreza
·
Wells Fargo
CenterPoint Energy price target lowered to $38 from $41 at Barclays
$38.00
(was $39.06)
Barclays
CenterPoint Energy upgraded to Outperform from Market Perform at BMO Capital
$42.00
(was $37.88)
BMO Capital
CenterPoint Energy price target lowered to $43 from $45 at UBS
$43.00
(was $38.05)
UBS
CenterPoint Energy price target lowered to $36 from $39 at Morgan Stanley
$36.00
(was $38.19)
David Arcaro
·
Morgan Stanley
CenterPoint Energy upgraded to Overweight from Sector Weight at KeyBanc
$41.00
(was $37.31)
Sophie Karp
·
KeyBanc
CenterPoint Energy initiated with an Overweight at Wells Fargo
$44.00
(was $39.74)
Shahriar Pourreza
·
Wells Fargo
CenterPoint Energy price target raised to $42 from $40 at Mizuho
$42.00
(was $40.01)
Mizuho Securities
CenterPoint Energy price target raised to $39 from $37 at Morgan Stanley
$39.00
(was $39.88)
Morgan Stanley